Volume 101 Number 12
Published online 8 December 2009 (1947 - 2078)
---------------------------------------------------------------------
British Journal of Cancer publishes high quality original papers and
reviews that make a significant contribution to increasing
understanding of the causes of cancer and to improving the treatment
and survival of patients.
Visit the journal online at http://links.ealert.nature.com/ctt?kn=34&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0 to view the
latest research and access selected articles FREE of charge.
---------------------------------------------------------------------
British Journal of Cancer has an impact factor of 4.846*
2008 Journal Citation Reports (Thomson Reuters, 2009)
----------------------
EDITORIAL
----------------------
Regarding: /`Epoetin [beta] treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events/'
G Schwarzer
http://links.ealert.nature.com/ctt?kn=76&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
MINIREVIEW
----------------------
Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
A M Traish and A Morgentaler
Abstract: http://links.ealert.nature.com/ctt?kn=75&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=74&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
S Tamez, C Norizoe, K Ochiai, D Takahashi, A Shimojima, Y Tsutsumi, N Yanaihara, T Tanaka, A Okamoto and M Urashima
Abstract: http://links.ealert.nature.com/ctt?kn=82&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=81&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Epoetin-[beta] treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
M Aapro, B Osterwalder, A Scherhag and H U Burger
Abstract: http://links.ealert.nature.com/ctt?kn=80&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=79&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
T Yoshioka, S Kato, M Gamoh, N Chiba, T Suzuki, N Sakayori, S Kato, H Shibata, H Shimodaira, K Otsuka, Y Kakudo, S Takahashi and C Ishioka
Abstract: http://links.ealert.nature.com/ctt?kn=110&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=113&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
P Bougnoux, N Hajjaji, M N Ferrasson, B Giraudeau, C Couet and O Le Floch
Abstract: http://links.ealert.nature.com/ctt?kn=15&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=17&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
D A Reardon, A Desjardins, J J Vredenburgh, S Gururangan, J H Sampson, S Sathornsumetee, R E McLendon, J E Herndon, J E Marcello, J Norfleet, A H Friedman, D D Bigner and H S Friedman
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=19&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
D A Reardon, G Dresemann, S Taillibert, M Campone, M van den Bent, P Clement, E Blomquist, L Gordower, H Schultz, J Raizer, P Hau, J Easaw, M Gil, J Tonn, A Gijtenbeek, U Schlegel, P Bergstrom, S Green, A Weir and Z Nikolova
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=21&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
V Bilim, A Ougolkov, K Yuuki, S Naito, H Kawazoe, A Muto, M Oya, D Billadeau, T Motoyama and Y Tomita
Abstract: http://links.ealert.nature.com/ctt?kn=20&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=24&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
W Zhong, J P Celli, I Rizvi, Z Mai, B Q Spring, S H Yun and T Hasan
Abstract: http://links.ealert.nature.com/ctt?kn=22&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=83&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
N Yokota, S Koizume, E Miyagi, F Hirahara, Y Nakamura, K Kikuchi, W Ruf, Y Sakuma, E Tsuchiya and Y Miyagi
Abstract: http://links.ealert.nature.com/ctt?kn=93&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=94&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
M Hirotsu, T Setoguchi, Y Matsunoshita, H Sasaki, H Nagao, H Gao, K Sugimura and S Komiya
Abstract: http://links.ealert.nature.com/ctt?kn=91&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=92&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Epac inhibits migration and proliferation of human prostate carcinoma cells
M Grandoch, A Rose, M ter Braak, V Jendrossek, H Rubben, J W Fischer, M Schmidt and A A Weber
Abstract: http://links.ealert.nature.com/ctt?kn=89&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=90&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
GENETICS AND GENOMICS
----------------------
Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families
A M Ray, K A Zuhlke, G R Johnson, A M Levin, J A Douglas, E M Lange and K A Cooney
Abstract: http://links.ealert.nature.com/ctt?kn=87&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=88&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, KConFab9, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, OCGN23, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernstrom, M S Askmalm, B Arver, B Malmer, SWE-BRCA37, S M Domchek, K L Nathanson, J Brunet, T Ramon y Cajal, D Yannoukakos, U Hamann, HEBON37, F B L Hogervorst, S Verhoef, EB Gomez Garcia, J T Wijnen, A van den Ouweland, EMBRACE37, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, GEMO596061, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Revillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, Breast Cancer Family Registry37, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Deiszler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice and J Benitez on behalf of CIMBA
Abstract: http://links.ealert.nature.com/ctt?kn=84&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=86&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Regarding: /`High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series/'
T S Clark
http://links.ealert.nature.com/ctt?kn=115&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Reply to TS Clark: /`High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series/'
H U Ahmed and M Emberton
http://links.ealert.nature.com/ctt?kn=103&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Regarding: /`High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series/'
S Eggener, M Gonzalgo and O Yossepowitch
http://links.ealert.nature.com/ctt?kn=107&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Reply to S Eggener, M Gonzalgo and O Yossepowitch: /`High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series/'
H U Ahmed and M Emberton
http://links.ealert.nature.com/ctt?kn=99&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Evolutionary game theory: lessons and limitations, a cancer perspective
J W McEvoy
http://links.ealert.nature.com/ctt?kn=102&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
Reply: Evolutionary game theory: lessons and limitations, a cancer perspective
D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck and J M Pacheco
http://links.ealert.nature.com/ctt?kn=54&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
CORRIGENDUM
----------------------
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
A-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, S Romeo, J Oosting, R M Egeler, H Gelderblom, A H M Taminiau and P C W Hogendoorn
http://links.ealert.nature.com/ctt?kn=51&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
AUTHOR INDEX
----------------------
Author Index for Volume 101
http://links.ealert.nature.com/ctt?kn=49&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
----------------------
KEYWORD INDEX
----------------------
Keyword Index for Volume 101
http://links.ealert.nature.com/ctt?kn=47&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware
that this journal is valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=32&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=30&m=34475714&r=MTc2MDAwMTgxNgS2&b=2&j=NjIxNTQ0NDYS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
